[1]
“Prostatic acinar adenocarcinoma: evaluation of IGFR expression as a possible target for targeted molecular therapies”, Work Paper Public Hlth, vol. 2, no. 1, Jun. 2013, doi: 10.4081/wpph.2013.6752.